We've found
1,035
archived clinical trials in
Bipolar Disorder
We've found
1,035
archived clinical trials in
Bipolar Disorder
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
Updated: 12/31/1969
52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
Updated: 12/31/1969
52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
Updated: 12/31/1969
52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
Updated: 12/31/1969
52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
Updated: 12/31/1969
52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
Updated: 12/31/1969
52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
Updated: 12/31/1969
52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
Updated: 12/31/1969
52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
Updated: 12/31/1969
52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
Updated: 12/31/1969
52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
Updated: 12/31/1969
52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
Updated: 12/31/1969
52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
Updated: 12/31/1969
52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
Updated: 12/31/1969
52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
Updated: 12/31/1969
52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
Updated: 12/31/1969
52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
Updated: 12/31/1969
52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
Updated: 12/31/1969
52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
Updated: 12/31/1969
52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
Updated: 12/31/1969
52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurophysiologic Correlates of Hypersomnia
Updated: 12/31/1969
Neurophysiologic Correlates of Hypersomnia: a High Density EEG Investigation
Status: Enrolling
Updated: 12/31/1969
Neurophysiologic Correlates of Hypersomnia
Updated: 12/31/1969
Neurophysiologic Correlates of Hypersomnia: a High Density EEG Investigation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Probiotics to Prevent Relapse After Hospitalization for Mania
Updated: 12/31/1969
A Double-Blind Placebo-Controlled Trial of a Probiotic Supplement to Prevent Relapse and Improve the Clinical Course After Hospitalization for Mania
Status: Enrolling
Updated: 12/31/1969
Probiotics to Prevent Relapse After Hospitalization for Mania
Updated: 12/31/1969
A Double-Blind Placebo-Controlled Trial of a Probiotic Supplement to Prevent Relapse and Improve the Clinical Course After Hospitalization for Mania
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Brief Sleep Intervention for Bipolar Disorder
Updated: 12/31/1969
Brief Sleep Intervention for Suicide in Bipolar Disorder
Status: Enrolling
Updated: 12/31/1969
Brief Sleep Intervention for Bipolar Disorder
Updated: 12/31/1969
Brief Sleep Intervention for Suicide in Bipolar Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI
Updated: 12/31/1969
Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI
Status: Enrolling
Updated: 12/31/1969
Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI
Updated: 12/31/1969
Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Vitamin D Supplementation for Bipolar Depression
Updated: 12/31/1969
Randomized Double-Blind Placebo-Controlled Pilot Study of Vitamin D Supplementation for the Treatment of Bipolar Depression
Status: Enrolling
Updated: 12/31/1969
Vitamin D Supplementation for Bipolar Depression
Updated: 12/31/1969
Randomized Double-Blind Placebo-Controlled Pilot Study of Vitamin D Supplementation for the Treatment of Bipolar Depression
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Vitamin D Supplementation for Bipolar Depression
Updated: 12/31/1969
Randomized Double-Blind Placebo-Controlled Pilot Study of Vitamin D Supplementation for the Treatment of Bipolar Depression
Status: Enrolling
Updated: 12/31/1969
Vitamin D Supplementation for Bipolar Depression
Updated: 12/31/1969
Randomized Double-Blind Placebo-Controlled Pilot Study of Vitamin D Supplementation for the Treatment of Bipolar Depression
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years Old
Updated: 12/31/1969
Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years Old With Bipolar I, Bipolar II and Bipolar Spectrum Disorder
Status: Enrolling
Updated: 12/31/1969
Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years Old
Updated: 12/31/1969
Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years Old With Bipolar I, Bipolar II and Bipolar Spectrum Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Get Moving and Get Well - Pilot Study
Updated: 12/31/1969
Get Moving and Get Well: A Behavioral Activation Program for Veterans With SMI
Status: Enrolling
Updated: 12/31/1969
Get Moving and Get Well - Pilot Study
Updated: 12/31/1969
Get Moving and Get Well: A Behavioral Activation Program for Veterans With SMI
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inositol Hexaphosphate: A Novel Treatment Strategy for Bipolar Disorder?
Updated: 12/31/1969
Inositol Hexaphosphate: A Novel Treatment Strategy for Bipolar Disorder?
Status: Enrolling
Updated: 12/31/1969
Inositol Hexaphosphate: A Novel Treatment Strategy for Bipolar Disorder?
Updated: 12/31/1969
Inositol Hexaphosphate: A Novel Treatment Strategy for Bipolar Disorder?
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ondansetron for Bipolar Disorder and Alcohol Use Disorders
Updated: 12/31/1969
Ondansetron for Bipolar Disorder and Alcohol Use Disorders
Status: Enrolling
Updated: 12/31/1969
Ondansetron for Bipolar Disorder and Alcohol Use Disorders
Updated: 12/31/1969
Ondansetron for Bipolar Disorder and Alcohol Use Disorders
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Improving Mental Health Outcomes: Building an Adaptive Implementation Strategy
Updated: 12/31/1969
Improving Mental Health Outcomes: Building an Adaptive Implementation
Status: Enrolling
Updated: 12/31/1969
Improving Mental Health Outcomes: Building an Adaptive Implementation Strategy
Updated: 12/31/1969
Improving Mental Health Outcomes: Building an Adaptive Implementation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Improving Mental Health Outcomes: Building an Adaptive Implementation Strategy
Updated: 12/31/1969
Improving Mental Health Outcomes: Building an Adaptive Implementation
Status: Enrolling
Updated: 12/31/1969
Improving Mental Health Outcomes: Building an Adaptive Implementation Strategy
Updated: 12/31/1969
Improving Mental Health Outcomes: Building an Adaptive Implementation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Updated: 12/31/1969
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Status: Enrolling
Updated: 12/31/1969
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Updated: 12/31/1969
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Updated: 12/31/1969
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Status: Enrolling
Updated: 12/31/1969
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Updated: 12/31/1969
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Dietary Intervention for Bipolar Disorder
Updated: 12/31/1969
Targeted Alterations in n-3 and n‐6 Fatty Acids for the Management of Mood Variability in the Maintenance Phase of Bipolar Disorder
Status: Enrolling
Updated: 12/31/1969
Dietary Intervention for Bipolar Disorder
Updated: 12/31/1969
Targeted Alterations in n-3 and n‐6 Fatty Acids for the Management of Mood Variability in the Maintenance Phase of Bipolar Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Open-Label Study of N-Acetylcysteine in Children and Adolescents 5-17 With Bipolar Spectrum Disorders
Updated: 12/31/1969
Open-Label Study of N-Acetylcysteine in Children and Adolescents Ages 5-17 With Bipolar I, Bipolar II, and Bipolar Spectrum Disorder
Status: Enrolling
Updated: 12/31/1969
Open-Label Study of N-Acetylcysteine in Children and Adolescents 5-17 With Bipolar Spectrum Disorders
Updated: 12/31/1969
Open-Label Study of N-Acetylcysteine in Children and Adolescents Ages 5-17 With Bipolar I, Bipolar II, and Bipolar Spectrum Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression
Updated: 12/31/1969
16-week Open Randomized Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression: Pharmacogenomic and Biomarker Predictors of Response
Status: Enrolling
Updated: 12/31/1969
16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression
Updated: 12/31/1969
16-week Open Randomized Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression: Pharmacogenomic and Biomarker Predictors of Response
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Targeting Cognition in Bipolar Disorder With Pramipexole
Updated: 12/31/1969
Pramipexole in Bipolar Disorder: Targeting Cognition (PRAM-BD)
Status: Enrolling
Updated: 12/31/1969
Targeting Cognition in Bipolar Disorder With Pramipexole
Updated: 12/31/1969
Pramipexole in Bipolar Disorder: Targeting Cognition (PRAM-BD)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Targeting Cognition in Bipolar Disorder With Pramipexole
Updated: 12/31/1969
Pramipexole in Bipolar Disorder: Targeting Cognition (PRAM-BD)
Status: Enrolling
Updated: 12/31/1969
Targeting Cognition in Bipolar Disorder With Pramipexole
Updated: 12/31/1969
Pramipexole in Bipolar Disorder: Targeting Cognition (PRAM-BD)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Targeting Cognition in Bipolar Disorder With Pramipexole
Updated: 12/31/1969
Pramipexole in Bipolar Disorder: Targeting Cognition (PRAM-BD)
Status: Enrolling
Updated: 12/31/1969
Targeting Cognition in Bipolar Disorder With Pramipexole
Updated: 12/31/1969
Pramipexole in Bipolar Disorder: Targeting Cognition (PRAM-BD)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Adjunctive Psychotherapy for Perinatal Bipolar Disorder
Updated: 12/31/1969
Adjunctive Psychotherapy for Perinatal Bipolar Disorder
Status: Enrolling
Updated: 12/31/1969
Adjunctive Psychotherapy for Perinatal Bipolar Disorder
Updated: 12/31/1969
Adjunctive Psychotherapy for Perinatal Bipolar Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental Illness
Updated: 12/31/1969
Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental Illness: Patient Engagement, Satisfaction, and Outcomes
Status: Enrolling
Updated: 12/31/1969
Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental Illness
Updated: 12/31/1969
Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental Illness: Patient Engagement, Satisfaction, and Outcomes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Exercise and Cognitive Training
Updated: 12/31/1969
Exercise and Cognitive Training
Status: Enrolling
Updated: 12/31/1969
Exercise and Cognitive Training
Updated: 12/31/1969
Exercise and Cognitive Training
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Updated: 12/31/1969
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Status: Enrolling
Updated: 12/31/1969
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Updated: 12/31/1969
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Updated: 12/31/1969
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Status: Enrolling
Updated: 12/31/1969
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Updated: 12/31/1969
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Emotion Recognition Modification for Bipolar Disorder
Updated: 12/31/1969
Emotion Recognition Modification for Bipolar Disorder
Status: Enrolling
Updated: 12/31/1969
Emotion Recognition Modification for Bipolar Disorder
Updated: 12/31/1969
Emotion Recognition Modification for Bipolar Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effectiveness of Two Self Assessment Tools: KIOS-Bipolar or eMoods
Updated: 12/31/1969
Comparative Effectiveness of Two Self Assessment Tools: KIOS-Bipolar or eMoods: A Randomized, Open 52 Week Study for Persons With Bipolar Disorder
Status: Enrolling
Updated: 12/31/1969
Effectiveness of Two Self Assessment Tools: KIOS-Bipolar or eMoods
Updated: 12/31/1969
Comparative Effectiveness of Two Self Assessment Tools: KIOS-Bipolar or eMoods: A Randomized, Open 52 Week Study for Persons With Bipolar Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study
Updated: 12/31/1969
Cerebellar Transcranial Magnetic Stimulation (cTMS) in Psychotic Disorders: Effect on Time Perception, Executive Function, and Mood and Psychotic Symptoms
Status: Enrolling
Updated: 12/31/1969
Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study
Updated: 12/31/1969
Cerebellar Transcranial Magnetic Stimulation (cTMS) in Psychotic Disorders: Effect on Time Perception, Executive Function, and Mood and Psychotic Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study
Updated: 12/31/1969
Cerebellar Transcranial Magnetic Stimulation (cTMS) in Psychotic Disorders: Effect on Time Perception, Executive Function, and Mood and Psychotic Symptoms
Status: Enrolling
Updated: 12/31/1969
Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study
Updated: 12/31/1969
Cerebellar Transcranial Magnetic Stimulation (cTMS) in Psychotic Disorders: Effect on Time Perception, Executive Function, and Mood and Psychotic Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Rostral Dorsal Cingulum Bundle Connectivity in Patients With Bipolar Disorder
Updated: 12/31/1969
Rostral Dorsal Cingulum Bundle Connectivity in Patients With Bipolar Disorder
Status: Enrolling
Updated: 12/31/1969
Rostral Dorsal Cingulum Bundle Connectivity in Patients With Bipolar Disorder
Updated: 12/31/1969
Rostral Dorsal Cingulum Bundle Connectivity in Patients With Bipolar Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness
Updated: 12/31/1969
Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness
Status: Enrolling
Updated: 12/31/1969
Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness
Updated: 12/31/1969
Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating The Efficacy, Safety And Tolerability Of Cariprazine In Patients With Bipolar I Depression
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating The Efficacy, Safety And Tolerability Of Cariprazine In Patients With Bipolar I Depression
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating The Efficacy, Safety And Tolerability Of Cariprazine In Patients With Bipolar I Depression
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating The Efficacy, Safety And Tolerability Of Cariprazine In Patients With Bipolar I Depression
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating The Efficacy, Safety And Tolerability Of Cariprazine In Patients With Bipolar I Depression
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating The Efficacy, Safety And Tolerability Of Cariprazine In Patients With Bipolar I Depression
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating The Efficacy, Safety And Tolerability Of Cariprazine In Patients With Bipolar I Depression
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating The Efficacy, Safety And Tolerability Of Cariprazine In Patients With Bipolar I Depression
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating The Efficacy, Safety And Tolerability Of Cariprazine In Patients With Bipolar I Depression
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating The Efficacy, Safety And Tolerability Of Cariprazine In Patients With Bipolar I Depression
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating The Efficacy, Safety And Tolerability Of Cariprazine In Patients With Bipolar I Depression
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating The Efficacy, Safety And Tolerability Of Cariprazine In Patients With Bipolar I Depression
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating The Efficacy, Safety And Tolerability Of Cariprazine In Patients With Bipolar I Depression
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating The Efficacy, Safety And Tolerability Of Cariprazine In Patients With Bipolar I Depression
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating The Efficacy, Safety And Tolerability Of Cariprazine In Patients With Bipolar I Depression
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating The Efficacy, Safety And Tolerability Of Cariprazine In Patients With Bipolar I Depression
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating The Efficacy, Safety And Tolerability Of Cariprazine In Patients With Bipolar I Depression
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating The Efficacy, Safety And Tolerability Of Cariprazine In Patients With Bipolar I Depression
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials